Compare BIO & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | AU |
|---|---|---|
| Founded | 1952 | 1944 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Precious Metals |
| Sector | Industrials | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 61.2B |
| IPO Year | N/A | 2023 |
| Metric | BIO | AU |
|---|---|---|
| Price | $242.56 | $105.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $339.75 | $119.00 |
| AVG Volume (30 Days) | 320.1K | ★ 1.9M |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $38.71 |
| Revenue Next Year | $3.20 | $2.89 |
| P/E Ratio | ★ $9.72 | $23.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $41.01 |
| 52 Week High | $343.12 | $129.14 |
| Indicator | BIO | AU |
|---|---|---|
| Relative Strength Index (RSI) | 29.88 | 56.70 |
| Support Level | N/A | $103.18 |
| Resistance Level | $311.53 | $114.56 |
| Average True Range (ATR) | 10.49 | 3.29 |
| MACD | -4.23 | 1.34 |
| Stochastic Oscillator | 2.83 | 69.08 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.